Oridupa Olayinka A, Folasire Oluyemisi F, Owolabi Adedotun J
J Complement Integr Med. 2017 Mar 10;14(2). doi: 10.1515/jcim-2016-0072.
Background Hematological and biochemical changes associated with diabetes mellitus and probable reversal were assessed in alloxan-induced diabetic Wistar rats fed with varied percentages of Xanthosoma sagittifolium corm feed (Xs). The changes were compared to normoglycemic rats and diabetic rats treated with glibenclamide. Methods The study had eight groups in all with group 8 (control) consisting of five normoglycemic rats fed with normal rat pellets (Nrp). Diabetes was experimentally induced by intraperitoneal injection of alloxan to normoglycemic rats. Diabetic rats (serum glucose >200 mg/dL) at 48 h postinjection were randomly divided into the seven groups, each diabetic group consisting of five rats. One group was untreated and fed with Nrp, four groups were fed with 25 %, 50 %, 75 % or 100 % Xs, one group was fed with 100 % Xs and administered with glibenclamide, while a 7th group was fed with Nrp and administered with glibenclamide. Results This study shows that treatment of diabetes with corm of X. sagittifolium increases cellular response to inflammation which is required for body defense against assaulting agents. Decreased serum protein levels observed in untreated diabetic rats were restored in diabetic rats fed with X. sagittifolium corm with particular increase in serum albumin levels but depression of globulin fraction, except in rats fed with X. sagittifolium feed and administered with glibenclamide. X. sagittifolium showed a potent antihyperglycemic effect and corrected the dyslipidemia in a manner comparable to that observed for glibenclamide. Although HDL levels were still low, significant (p<0.05) decrease of LDL levels was a positive indicator of reduced risk for development of cardiovascular and/or coronary heart disease. Conclusions X. sagittifolium corm can be recommended for inclusion in diets of diabetics without causing further deterioration of health of the diabetic patients.
在以不同比例的箭叶黄体芋球茎饲料(Xs)喂养的四氧嘧啶诱导的糖尿病Wistar大鼠中,评估了与糖尿病相关的血液学和生化变化以及可能的逆转情况。将这些变化与正常血糖大鼠和用格列本脲治疗的糖尿病大鼠进行比较。方法:该研究共有八组,第8组(对照组)由五只喂食正常大鼠颗粒饲料(Nrp)的正常血糖大鼠组成。通过向正常血糖大鼠腹腔注射四氧嘧啶实验性诱导糖尿病。注射后48小时血糖>200mg/dL的糖尿病大鼠被随机分为七组,每组糖尿病组由五只大鼠组成。一组不治疗并喂食Nrp,四组分别喂食25%、50%、75%或100%的Xs,一组喂食100%的Xs并给予格列本脲,而第七组喂食Nrp并给予格列本脲。结果:本研究表明,用箭叶黄体芋球茎治疗糖尿病可增加细胞对炎症的反应,这是身体抵御攻击因子所必需的。未治疗的糖尿病大鼠中观察到的血清蛋白水平降低在喂食箭叶黄体芋球茎的糖尿病大鼠中得到恢复,血清白蛋白水平尤其升高,但球蛋白部分降低,喂食箭叶黄体芋球茎饲料并给予格列本脲的大鼠除外。箭叶黄体芋显示出强大的降血糖作用,并以与格列本脲相当的方式纠正了血脂异常。尽管高密度脂蛋白(HDL)水平仍然较低,但低密度脂蛋白(LDL)水平显著降低(p<0.05)是心血管和/或冠心病发病风险降低的积极指标。结论:箭叶黄体芋球茎可推荐纳入糖尿病患者饮食中,而不会导致糖尿病患者健康状况进一步恶化。